A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/25/1997	US5691346 Castanospermine as an anti-inflammatory and immunosuppressant agent
11/25/1997	US5691344 Vasoconstrictive substituted dihydropyranopyridines
11/25/1997	US5691343 Crohn*s disease
11/25/1997	US5691340 Benzopyran derivatives
11/25/1997	US5691339 Circulatory disorder improving agent
11/25/1997	US5691338 1,2-dithiole-3 thiones for the treatment of reverse transcriptase-dependent viral infections
11/25/1997	US5691337 Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents
11/25/1997	US5691336 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
11/25/1997	US5691334 Immunomodulators for skin grafts, autoimmune and for organ transplants
11/25/1997	US5691332 Antiarrhymia agents and cardiovascular disorders
11/25/1997	US5691331 N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
11/25/1997	US5691327 Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy
11/25/1997	US5691325 Method for ameliorating age-related disease conditions
11/25/1997	US5691324 Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions
11/25/1997	US5691320 Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis
11/25/1997	US5691319 Anticarcinogenic agents
11/25/1997	US5691318 Nervous system disorders and medical diagnosis
11/25/1997	US5691317 Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP dependent protein kinases for the treatment of cancer
11/25/1997	US5691306 Protein secretion
11/25/1997	US5691201 Use of sabeluzole in chronic neurodegenerative diseases
11/25/1997	US5691190 Phaffia rhodozyma mutants, process for producing β-carotene and use of β-carotene rich biomass
11/25/1997	US5691167 DNA encoding allergenic proteins and peptides from Johnson grass pollen
11/25/1997	US5691132 Method for inactivating pathogens in red cell compositions using quinacrine mustard
11/25/1997	US5690967 Compositions for improved topical delivery of lactic acid
11/25/1997	US5690962 Mixing with group 1a compound
11/25/1997	US5690961 Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
11/25/1997	US5690960 Magnesium salt; oral form
11/25/1997	US5690955 Wound dressing
11/25/1997	US5690946 Cosmetic and/or dermatological composition containing thermal spring water or mineral water and an active agent, in order to combat acne or aging
11/25/1997	US5690944 Cosmetic compositions containing lactate dehydrogenase inhibitors
11/25/1997	US5690929 Use of methioninase and chemotherapy agents in chemotherapy
11/25/1997	US5690927 Use of neuro-glial fetal cell lines for transplantation therapy
11/25/1997	US5690924 Hair treatment compositions
11/25/1997	US5690923 Stable topical retinoid compositions
11/25/1997	US5690919 Using mixture of dodecanoic acid, another fatty acid andglycerol ester
11/25/1997	US5690910 Administering heparins
11/25/1997	CA2132541C Quinuclidine derivatives as substance p antagonists
11/25/1997	CA2113567C Benzimidazole anthelmintics
11/25/1997	CA2101518C Neuroleptic perhydro-1h-pyrido¬1,2-a\|pyrazines
11/25/1997	CA2077598C Alkoxy substituted taxanes and pharmaceutical compositions containing them
11/25/1997	CA2050587C Bicyclolactam derivative
11/25/1997	CA1339558C Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
11/24/1997	CA2205940A1 Medicament comprising a carnitine derivative for treating alzheimer's disease in early-onset patients
11/22/1997	CA2205785A1 Sulfur-containing heterocyclic bradykinin antagonists, process for their preparation, and their use
11/22/1997	CA2205780A1 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith
11/20/1997	WO1997043643A1 Inhibitors of pseudomonas aeruginosa induced mucin production: compositions and treatments for cystic fibrosis patients
11/20/1997	WO1997043436A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
11/20/1997	WO1997043431A1 Vehicle for the transport of molecular substances
11/20/1997	WO1997043362A1 Sterol extraction with polar solvent to give low sterol, high triglyceride, microbial oil
11/20/1997	WO1997043311A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
11/20/1997	WO1997043310A1 Synthetic inhibitors of hepatitis c virus ns3 protease
11/20/1997	WO1997043306A1 Neuroactive peptides
11/20/1997	WO1997043305A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
11/20/1997	WO1997043304A1 Novel compounds
11/20/1997	WO1997043303A1 Novel compounds
11/20/1997	WO1997043300A1 Adenosine derivatives
11/20/1997	WO1997043299A1 Alkylated nucleoside-3'-phosphates, process for producing them and their use
11/20/1997	WO1997043297A1 Novel method for isomerising the 10-methyl radical of erythromycin derivatives
11/20/1997	WO1997043291A1 Taxane derivatives, the preparation thereof and formulations containing them
11/20/1997	WO1997043290A1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
11/20/1997	WO1997043288A1 Novel imidazopyridines
11/20/1997	WO1997043287A1 Carboline derivatives
11/20/1997	WO1997043280A1 3-phenyl-furan-(5h)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
11/20/1997	WO1997043279A1 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists
11/20/1997	WO1997043278A1 Somatostatin agonists and antagonists
11/20/1997	WO1997043277A1 2,4-diaminopyrimidine derivatives
11/20/1997	WO1997043276A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
11/20/1997	WO1997043273A1 Substituted 1, 3-benzodioxoles
11/20/1997	WO1997043272A2 Benzofurans and benzopyrans as chronobiological agents
11/20/1997	WO1997043271A1 Alkylaminobenzothiazole and -benzoxazole derivatives
11/20/1997	WO1997043268A1 8-hydrocarbyl substituted benzodizocine derivatives, their preparation and their use as protein kinase c (=pkc) modulators
11/20/1997	WO1997043266A1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
11/20/1997	WO1997043262A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/20/1997	WO1997043260A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997	WO1997043259A1 Arylalkylpiperazine compounds as antioxidants
11/20/1997	WO1997043258A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/20/1997	WO1997043251A1 Compounds with anti-inflammatory and immunosuppressive activities
11/20/1997	WO1997043250A1 Hydroxamic acid based inhibitors of the formation of cd23 and tnf
11/20/1997	WO1997043249A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
11/20/1997	WO1997043247A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997043235A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
11/20/1997	WO1997042980A1 Methods of terminal sterilization of biological products
11/20/1997	WO1997042979A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	WO1997042975A2 Chitosan related compositions for delivery of nucleic acids into a cell
11/20/1997	WO1997042971A1 Recombinant neospora antigens and their uses
11/20/1997	WO1997042970A1 Depigmentating agent in the treatment of melasma
11/20/1997	WO1997042969A1 USE OF IL-12 AND IFN-α FOR THE TREATMENT OF INFECTIOUS DISEASES
11/20/1997	WO1997042968A2 Administration of histamine for therapeutic purposes
11/20/1997	WO1997042967A1 Antithrombotic materials and methods
11/20/1997	WO1997042966A1 Therapeutic uses of bpi protein products for human meningococcemia
11/20/1997	WO1997042964A1 Method and product for promoting hair growth and treating skin conditions
11/20/1997	WO1997042962A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/20/1997	WO1997042961A1 Pharmacological association between n-acetylcystein and levulose for preventing cellular death and related diseases
11/20/1997	WO1997042960A1 Ascorbyl-phosphoryl-cholesterol
11/20/1997	WO1997042959A1 Emergency contraceptive kit

1 ... 6721 6722 6723 6724 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 6735 6736 6737 6738 6739 6740 6741 ... 7860